本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aquestive Therapeutics Inc.

2.51
+0.01000.40%
盘后2.520.0108+0.43%19:25 EDT
成交量:110.56万
成交额:277.59万
市值:2.48亿
市盈率:-4.93
高:2.58
开:2.50
低:2.47
收:2.50
数据加载中...

公司资料

公司名字:
Aquestive Therapeutics Inc.
交易所:
NASDAQ
成立时间:
2004
员工人数:
142
公司地址:
30 Technology Drive,Warren,New Jersey,United States
邮编:
07059
电话:
传真:
- -
简介:
Aquestive Therapeutics, Inc.于2004年1月在特拉华州成立。Aquestive是一家推进药物的制药公司,通过创新的科学和递送技术为患者的生活带来有意义的改善。该公司正在开发医药产品,通过替代侵入性和不方便的标准护理疗法的给药来递送复杂的分子。Aquestive还与制药公司合作,利用PharmFilm等专有、同类最佳技术将新分子推向市场,并已证明具有药物开发和商业化能力。该公司还开发了专注于治疗中枢神经系统疾病的产品管线。

董事

名称
职位
John Cochran
Vice Chairman of the Board
Keith J. Kendall
Chief Executive Officer, President and Director
Santo Costa
Chairman of the Board
James S. Scibetta
Director
Julie Krop
Director
Marco Taglietti
Director
Nancy Lurker
Director

股东

名称
职位
Keith J. Kendall
Chief Executive Officer, President and Director
Daniel Barber
Senior Vice President - Chief Operating Officer
A. Ernest Toth, Jr.
Interim Chief Financial Officer
Gary H. Slatko
Senior Vice President - Chief Medical Officer
Ken Marshall
Senior Vice President - Chief Commercial Officer
Lori J. Braender
Senior Vice President - General Counsel, Chief Compliance Officer and Corporate Secretary
Peter Boyd
Senior Vice President - Business Process and Information Technology
Theresa Wood
Senior Vice President - Human Resources and Organizational Development
A. Mark Schobel
Chief Innovation and Technology Officer